Test Update - PSA Referral Limit Update
26 August 2026
Change to PSA Age-Adjusted Referral Thresholds. From Monday 7th September 2026, Pathlab will adopt the age-adjusted PSA referral thresholds as outlined in the September 2025 Prostate Cancer OCCP. Due to reporting restrictions, the referral thresholds will be reflected as the reference interval reported alongside the PSA level. These limits should not be interpreted as population reference interval…
Keep Reading →
Myoglobin Testing Withdrawn
18 August 2026
Waikato Hospital Laboratory will stop offering myoglobin (blood and urine) from 17 August 2026 onwards. Consequently, myoglobin screening will no longer be offered by Pathlab. This decision is associated with the implementation of a new Laboratory Information System (LIS) at Waikato Hospital Laboratory. During the project, the software vendor advised that the calculation required for urine myoglob…
Keep Reading →
Requesting Short Synacthen Testing in the Community
11 August 2026
Over recent weeks, we have received several enquiries regarding how community patients can access Short Synacthen Testing across Pathlab's main regions. Please see below the referral and booking requirements for each region: Tauranga: Bookings are essential and can be made through the Pathlab Contact Centre – 07 578 7073. Testing is only available at Pathlab Cameron Road, Tauranga Hospital Campus.…
Keep Reading →
Pathlab Haematopathologist Service
31 July 2026
As part of our ongoing commitment to supporting high-quality patient care and ensuring the best use of available healthcare resources across the region, we would like to provide some guidance on the scope of the Pathlab Haematopathologist consultation service. We hope this information will assist clinicians in accessing the most appropriate specialist advice and help ensure enquiries are directed…
Keep Reading →
TnI Female Interval Update
29 July 2026
Change to Female Troponin I Upper Reference Limit Please be advised that, effective 1 August 2026, the upper reference limit (URL) for high-sensitivity Troponin I (hsTnI) in females will change to 12 ng/L. This revision aligns the female URL with the 99th percentile reference limit established for the Beckman Coulter hsTnI assay, which is the method currently used across Pathlab laboratories. Ther…
Keep Reading →